Role of FDG (18F) PET in paraneoplastic neurological syndromes

被引：1

作者：

Daragon, N. ^{[1
]}

Desarnaud, S. ^{[1
]}

Kas, A. ^{[1
]}

Maksud, P. ^{[1
]}

Houzard, C. ^{[2
]}

Pina-Jomir, G. ^{[3
]}

Farid, K. ^{[4
]}

Abulizi, M. ^{[1
]}

Habert, M. -O. ^{[1
]}

机构：

[1] Grp Hosp Pitie Salpetriere, Nucl Med Serv, F-75651 Paris 13, France

[2] CHU Lyon Sud, Nucl Med Serv, F-69495 Pierre Benite, France

[3] CHU Lyon Pole Est, Ctr Med Nucl, F-69677 Bron, France

[4] Hop Hotel Dieu, Nucl Med Serv, F-75181 Paris 04, France

来源：

MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2010年 / 34卷 / 07期

关键词：

FDG PET; Paraneoplastic neurological syndromes; RECOMMENDED DIAGNOSTIC-CRITERIA; POSITRON-EMISSION-TOMOGRAPHY; TUMOR; MALIGNANCY; MANAGEMENT; MRI;

D O I：

10.1016/j.mednuc.2010.05.008

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Paraneoplastic neurological syndromes (PNS) are rare non-metastatic manifestations of cancer. However, in this family of diseases, to recognize the underlying malignancy is an emergency. The ultimate aim is to treat the patient and try to stabilize or improve the neurological dysfunction, which is frequently the cause of the patient's death. The yield of FDG PET seems to be poor in unselected PNS. In the last decade, neurologists have attempted to provide more rigorous diagnostic criteria for PNS. Thus, "classical" PNS and a panel of "well-characterized" onconeural antibodies have been defined in order to facilitate triage of patients for whom FDG PET would be more sensitive. Currently, given the limited availability of PET cameras in France, this examination should be performed in the presence of either a "classical" PNS with or without onconeuralantibodies positivity or other PNS with onconeural antibodies positivity. The FOG PET should be triggered after a negative conventional imasing work up. (C) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：399 / 405

页数：7

共 21 条

[1] Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates [J].

Ances, BM ;

Vitaliani, R ;

Taylor, RA ;

Liebeskind, DS ;

Voloschin, A ;

Houghton, DJ ;

Galetta, SL ;

Dichter, M ;

Alavi, A ;

Rosenfeld, MR ;

Dalmau, J .

BRAIN, 2005, 128 :1764-1777

[2]

Antoine JC, 2000, ANN NEUROL, V48, P105, DOI 10.1002/1531-8249(200007)48:1<105::AID-ANA16>3.0.CO

[3]

2-G

[4] 18F-FDG-PET/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis [J].

Bannas, Peter ;

Weber, Christoph ;

Derlin, Thorsten ;

Lambert, Joerg ;

Leypoldt, Frank ;

Adam, Gerhard ;

Mester, Janos ;

Klutmann, Susanne .

EUROPEAN RADIOLOGY, 2010, 20 (04) :923-930

[5] Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: Detection of the underlying malignancy and the brain PET-MRI correlates [J].

Basu, Sandip ;

Alavi, Abass .

MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (03) :131-137

[6] Paraneoplastic neurological disorders [J].

Didelot, A. ;

Honnorat, J. .

ONCOLOGIE, 2009, 11 (02) :83-89

[7] Paraneoplastic Cataplexy: Clinical Presentation and Imaging Findings in a Case [J].

Farid, Karim ;

Jeannin, Severine ;

Lambrecq, Virginie ;

Philip, Pierre ;

Fernandez, Philippe ;

Molinier, Sandrine ;

Allard, Michele ;

Sibon, Igor .

MOVEMENT DISORDERS, 2009, 24 (12) :1854-1856

[8] Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration [J].

Frings, M ;

Antoch, G ;

Knorn, P ;

Freudenberg, L ;

Bier, U ;

Timmann, D ;

Maschke, M .

JOURNAL OF NEUROLOGY, 2005, 252 (02) :197-201

[9] Paraneoplastic Neurologic Syndrome in the PNS Euronetwork Database A European Study From 20 Centers [J].

Giometto, Bruno ;

Grisold, Wolfgang ;

Vitaliani, Roberta ;

Graus, Francesc ;

Honnorat, Jerome ;

Bertolini, Guido .

ARCHIVES OF NEUROLOGY, 2010, 67 (03) :330-335

[10]

Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447

← 1 2 3 →